Axcelis Technologies is under scrutiny after Craig Hallum issued a downgrade, impacting investor sentiment.

Axcelis Technologies anticipates approximately $205 million in revenue and $0.90 in EPS for Q2 2026, with a gross margin target of around 43%.

Axcelis Technologies (ACLS) stock experienced a significant drop of 16.7% following a disappointing forecast for 2025.

Axcelis Technologies anticipates flat revenue in 2026, with growth in the memory sector expected to offset declines in power and mature markets.

Highlights from Axcelis Technologies' first-quarter earnings call have been released, detailing the company's financial performance and outlook.

Exclusive | A Nuclear-Power Startup Says It Can Rouse the Slow-Moving Industry  The Wall Street Journal

Several companies, including AtriCure, RB Global, Beta Bionics, Axcelis Technologies, and Medifast, have released highlights from their fourth-quarter earnings calls.

A Vice President at Axcelis Technologies sold 2,000 shares of the company, prompting questions among investors about the implications of this transaction.

LIS Technologies Inc. has announced it will deliver the opening keynote presentation and serve as a platinum sponsor for Reuters Events' SMR and Advanced Reactor 2026 Conference.

Axcelis Technologies, Inc. has released a summary of its fourth-quarter 2025 earnings call, detailing its financial performance.

Axcelis Technologies posted a non-GAAP EPS of $1.49, beating estimates by $0.37, and revenue of $238.33M, surpassing by $23.28M.